These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11434385)

  • 61. [Changes of serum matrix metalloproteinases-9 and tissue inhibitors of metalloproteinases-9 in coal workers' pneumoconiosis].
    Zou JM; Yuan BJ; Wang DM; Li C; Wu JY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Jan; 28(1):21-4. PubMed ID: 20426972
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of biomarker panels as predictors of severity in coronary artery disease.
    Ben Braiek A; Chahed H; Dumont F; Abdelhak F; Hichem D; Gamra H; Baudin B
    J Cell Mol Med; 2021 Feb; 25(3):1518-1530. PubMed ID: 33381894
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aberrant plasma MMP and TIMP dynamics in Schistosoma - Immune reconstitution inflammatory syndrome (IRIS).
    Goovaerts O; Mwinzi PNM; Muok EMO; Ceulemans A; Colebunders R; Kestens L
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006710. PubMed ID: 30089120
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis.
    Marchesi C; Dentali F; Nicolini E; Maresca AM; Tayebjee MH; Franz M; Guasti L; Venco A; Schiffrin EL; Lip GY; Grandi AM
    J Hypertens; 2012 Jan; 30(1):3-16. PubMed ID: 22134384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Helminth Coinfection Is Associated With Enhanced Plasma Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Tuberculous Lymphadenitis.
    Kathamuthu GR; Moideen K; Thiruvengadam K; Sridhar R; Baskaran D; Babu S
    Front Cell Infect Microbiol; 2021; 11():680665. PubMed ID: 34350132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
    Schäfer M; Ivy DD; Nguyen K; Boncella K; Frank BS; Morgan GJ; Miller-Reed K; Truong U; Colvin K; Yeager ME
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H242-H252. PubMed ID: 34085841
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study.
    Nambi V; Morrison AC; Hoogeveen RC; Coresh J; Miles S; Rhodes CE; Sharrett AR; Boerwinkle BE; Ballantyne CM
    Tex Heart Inst J; 2008; 35(4):388-94. PubMed ID: 19156230
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
    Todd JL; Vinisko R; Liu Y; Neely ML; Overton R; Flaherty KR; Noth I; Newby LK; Lasky JA; Olman MA; Hesslinger C; Leonard TB; Palmer SM; Belperio JA;
    BMC Pulm Med; 2020 Mar; 20(1):64. PubMed ID: 32171287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure.
    Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Stroud RE; McKelvie RS; Liu PP
    Eur J Heart Fail; 2008 Feb; 10(2):125-8. PubMed ID: 18234554
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients.
    Sundararajan S; Babu S; Das SD
    Hum Immunol; 2012 Oct; 73(10):985-91. PubMed ID: 22820625
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.
    Olivares-Urbano MA; Griñán-Lisón C; Zurita M; Del Moral R; Ríos-Arrabal S; Artacho-Cordón F; Arrebola JP; González AR; León J; Antonio Marchal J; Núñez MI
    J Cell Mol Med; 2020 Jan; 24(1):139-148. PubMed ID: 31568637
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is high high-density lipoprotein cholesterol beneficial for premature coronary heart disease? A meta-analysis.
    Shahid M; Sun RL; Liu Y; Bao JL; Huang CX; Liao Y; Zhou SX; Wang JF; Zhang YL
    Eur J Prev Cardiol; 2016 May; 23(7):704-13. PubMed ID: 26464294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy.
    Essa EM; Zile MR; Stroud RE; Rice A; Gumina RJ; Leier CV; Spinale FG
    J Card Fail; 2012 Jun; 18(6):487-92. PubMed ID: 22633307
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Matrix Metalloproteinases Increase Because of Hypoperfusion in Obstructive Hypertrophic Cardiomyopathy.
    Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
    Ann Thorac Surg; 2021 Mar; 111(3):915-922. PubMed ID: 32738221
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Features of The Dynamics of Profibrotic Markers and Regression of Left Ventricular Hypertrophy After Renal Denervation in Patients With Resistant Hypertension and Stenosing Atherosclerosis of the Coronary Arteries.
    Zyubanova IV; Falkovckaya AY; Manukyan MA; Solonskaya EI; Vtorushina AA; Khunkhinova SA; Gusakova AM; Pekarskiy SE; Mordovin VF
    Kardiologiia; 2024 Apr; 64(4):45-53. PubMed ID: 38742515
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
    Jong GP; Wang YF; Tsai FJ; Tsai CH; Wu CL; Liu RH; Hsieh DJ; Ko FY; Huang CY; Lee SD
    Chin J Physiol; 2007 Dec; 50(6):277-82. PubMed ID: 18442010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines.
    Tziakas DN; Chalikias GK; Hatzinikolaou HI; Parissis JT; Papadopoulos ED; Trypsianis GA; Papadopoulou E; Tentes IK; Karas SM; Hatseras DI
    Int J Cardiol; 2003 Dec; 92(2-3):169-75. PubMed ID: 14659849
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biomarkers to estimate the probability of complicated appendicitis.
    Daly MC; von Allmen D; Wong HR
    J Pediatr Surg; 2018 Mar; 53(3):437-440. PubMed ID: 28951011
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of MMPs and TIMPs With the Occurrence of Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Liu Y; Xu B; Wu N; Xiang Y; Wu L; Zhang M; Wang J; Chen X; Li Y; Zhong L
    Can J Cardiol; 2016 Jun; 32(6):803-13. PubMed ID: 26907578
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension.
    Tiede SL; Wassenberg M; Christ K; Schermuly RT; Seeger W; Grimminger F; Ghofrani HA; Gall H
    Int J Cardiol; 2016 Nov; 223():821-826. PubMed ID: 27575785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.